Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.680
-0.100 (-5.62%)
At close: Apr 1, 2025, 4:00 PM
1.739
+0.059 (3.52%)
After-hours: Apr 1, 2025, 4:52 PM EDT

Vigil Neuroscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-84.26-82.64-68.31-43.28-57.09
Depreciation & Amortization
0.450.40.080.03-
Asset Writedown & Restructuring Costs
----41.85
Loss (Gain) From Sale of Investments
-1.56-1.49---
Stock-Based Compensation
10.128.95.482.090.52
Other Operating Activities
1.411.360.931.182.66
Change in Accounts Payable
0.020.01-2.482.352.21
Change in Unearned Revenue
20.01----
Change in Other Net Operating Assets
2.593.09-0.85-1.71-0.51
Operating Cash Flow
-51.22-70.36-65.15-39.35-10.36
Capital Expenditures
-0.01-0.67-0.92-0.2-
Sale (Purchase) of Intangibles
-----1
Investment in Securities
8.77-64.46---
Investing Cash Flow
8.76-65.14-0.92-0.2-1
Total Debt Issued
----10
Long-Term Debt Repaid
--0.02-0.04-0.04-
Net Debt Issued (Repaid)
--0.02-0.04-0.0410
Issuance of Common Stock
9.680.91140.620.040
Other Financing Activities
--20.68-1.89-
Financing Cash Flow
29.490.89161.26107.7559.66
Net Cash Flow
-12.97-134.6195.1968.248.3
Free Cash Flow
-51.23-71.04-66.07-39.55-10.36
Free Cash Flow Per Share
-1.26-1.83-2.08-25.82-7.68
Levered Free Cash Flow
-21.95-40.06-41.43-22.5-
Unlevered Free Cash Flow
-21.95-40.06-41.43-22.5-
Change in Net Working Capital
-23.53-6.853.01-2.1-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q